SLC39A1 and thymoma: Our analysis demonstrated significant overexpression of SLC39A1 (Supplementary Figure S1) in brain lower grade glioma (LGG), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), glioblastoma multiforme (GBM), testicular germ cell tumors (TGCT), thymoma (THYM), LIHC, and PAAD.